Investing Profile

Chris Nave

InvestorVC
Managing Director at Brandon Capital Partners
Photo of Chris Nave, Managing Director at Brandon Capital Partners

Signal uses Gmail to reveal intro paths. Email content is never read.

Sign in with Google →
cb
Brandon Capital Partners Managing Director
$100K - $5.0M
$1.5M
18
$404.5M
CompanyStageDateRound SizeTotal Raised
Denteric
GrantJul 2022
Series ASep 2019$9M
$9M
Ena Respiratory
Series UnknownJun 2021$24M
Series ASep 2020$8M
Series UnknownMay 2017$5M
$37M
Co-investors: Christopher Smith (Brandon Capital Partners)
Azura Ophthalmics
Series COct 2020$20M
Series BOct 2017$16M
$36M
Co-investors: Heather Preston
EBR Systems
Private EquityAug 2019$30M
Private EquityNov 2017$50M
$140M
Co-investors: Jason Lettmann (Morgenthaler Ventures)
Certa Therapeutics
GrantJun 2018$19M
$19M
OccuRx
Series UnknownMay 2015$5M
$5M
Spinifex Pharmaceuticals
Series CApr 2014$45M
Series BAug 2011$19M
Series ASep 2008$10M
Series AJul 2005$2M
$76M
Co-investors: Brent Ahrens (Canaan Partners), Heath Lukatch (Red Tree Venture Capital)
PolyActiva
Series BFeb 2013$10M
$10M